Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Regen BioPharma, Inc. RGBPP

Set alert

Price alert · RGBPP

All alert types
0.00 USD 0.00 -25.81%

At close · Oct 30

0.0008 Day range 0.0016
0.0009 52-week range 0.068
YTD
-93.61%
1 year
-98.15%
Open
0.0016
Prev close
0.00155
Mkt cap
85.91K
Vol
6.48M
Avg vol
290.81K
EPS
-0.017
P/E
0.00
More statistics
Low
0.0008
High
0.0016

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for RGBPP has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-141.60 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.2×
FY 2016: -2.3×FY 2017: -0.6×FY 2018: -0.2×FY 2019: -0.4×FY 2020: 0.1×FY 2021: -13.5×FY 2022: 13.6×FY 2023: 6.4×FY 2024: -0.6×FY 2025: -0.2×
FY 2016 5y median -0.2× FY 2025
P/S 1.3×
FY 2016: 79.9×FY 2017: 30.2×FY 2018: 8.5×FY 2019: 10.4×FY 2020: 1.9×FY 2021: 268×FY 2022: 65.0×FY 2023: 27.0×FY 2024: 1.8×FY 2025: 1.3×
FY 2016 5y median 27.0× FY 2025
P/B -0.1×
FY 2016: -13.6×FY 2017: -0.6×FY 2018: -0.1×FY 2019: -0.1×FY 2020: -0.0×FY 2021: -3.4×FY 2022: -1.9×FY 2023: -1.3×FY 2024: -0.1×FY 2025: -0.1×
FY 2016 5y median -1.3× FY 2025
P/FCF -0.8×
FY 2016: -4.8×FY 2017: -1.8×FY 2018: -0.5×FY 2019: -2.4×FY 2020: 11.3×FY 2021: -40.6×FY 2022: -25.2×FY 2023: -36.7×FY 2024: -0.6×FY 2025: -0.8×
FY 2016 5y median -25.2× FY 2025
EV/EBITDA -1.1×
FY 2016: -2.5×FY 2017: -0.8×FY 2018: -1.2×FY 2019: 6.7×FY 2020: 0.6×FY 2021: -7.7×FY 2022: 6.0×FY 2023: 5.8×FY 2024: -3.0×FY 2025: -1.1×
FY 2016 5y median -1.1× FY 2025
EV/Sales 4.7×
FY 2016: 82.3×FY 2017: 34.0×FY 2018: 22.8×FY 2019: 29.8×FY 2020: 25.6×FY 2021: 285×FY 2022: 70.2×FY 2023: 29.7×FY 2024: 5.2×FY 2025: 4.7×
FY 2016 5y median 29.7× FY 2025
FCF Yield -120.8%
FY 2016: -20.9%FY 2017: -57.1%FY 2018: -185.3%FY 2019: -42.3%FY 2020: 8.8%FY 2021: -2.5%FY 2022: -4.0%FY 2023: -2.7%FY 2024: -164.2%FY 2025: -120.8%
FY 2016 5y median -4.0% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 85.4%FY 2022: 78.8%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -143.1%
FY 2016: -2957.0%FY 2017: -2282.7%FY 2018: -1426.0%FY 2019: -688.2%FY 2020: -190.0%FY 2021: -117.4%FY 2022: -144.4%FY 2023: -290.4%FY 2024: -176.3%FY 2025: -143.1%
FY 2016 5y median -144.4% FY 2025
Net Margin -538.8%
FY 2016: -3414.0%FY 2017: -5308.2%FY 2018: -4715.0%FY 2019: -2384.5%FY 2020: 2483.6%FY 2021: -3951.7%FY 2022: 945.6%FY 2023: 432.9%FY 2024: -282.4%FY 2025: -538.8%
FY 2016 5y median -282.4% FY 2025
ROE 20.3%
FY 2016: 581.7%FY 2017: 111.2%FY 2018: 51.7%FY 2019: 24.0%FY 2020: -37.2%FY 2021: 50.2%FY 2022: -27.7%FY 2023: -20.1%FY 2024: 12.9%FY 2025: 20.3%
FY 2016 5y median 12.9% FY 2025
ROIC 6.2%
FY 2016: 903.3%FY 2017: 55.1%FY 2018: 18.5%FY 2019: 8.6%FY 2020: 4.4%FY 2021: 2.0%FY 2022: 5.0%FY 2023: 15.8%FY 2024: 9.5%FY 2025: 6.2%
FY 2016 5y median 6.2% FY 2025
ROA -464.1%
FY 2016: -1069.0%FY 2017: -618.4%FY 2018: -2255.8%FY 2019: -2647.2%FY 2020: 2217.7%FY 2021: -558.1%FY 2022: 398.4%FY 2023: 289.6%FY 2024: -376.1%FY 2025: -464.1%
FY 2016 5y median -376.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -47.9%FY 2017: 10.0%FY 2018: -9.1%FY 2019: 10.0%FY 2020: 0.0%FY 2021: 55.6%FY 2022: 37.6%FY 2023: 0.4%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 18.8%
FY 2016: -49.4%FY 2017: 15.1%FY 2018: 43.2%FY 2019: 46.9%FY 2020: 72.4%FY 2021: 3.8%FY 2022: -69.2%FY 2023: -102.1%FY 2024: 39.3%FY 2025: 18.8%
FY 2016 FY 2025
EPS (diluted) 66.1%
FY 2016: 79.0%FY 2017: -54.6%FY 2018: 24.9%FY 2019: 95.8%FY 2020: 197.4%FY 2021: -188.9%FY 2022: 121.3%FY 2023: -61.1%FY 2024: -214.3%FY 2025: 66.1%
FY 2016 FY 2025
Free Cash Flow 44.7%
FY 2016: 84.8%FY 2017: -13.3%FY 2018: 16.7%FY 2019: 69.5%FY 2020: 103.9%FY 2021: -6165.6%FY 2022: 46.3%FY 2023: 71.3%FY 2024: -298.5%FY 2025: 44.7%
FY 2016 FY 2025

Financial Health

Current Ratio 0.0×
FY 2016: 0.3×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Quick Ratio 0.0×
FY 2016: 0.3×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Debt / Equity -0.1×
FY 2016: -0.4×FY 2017: -0.1×FY 2018: -0.2×FY 2019: -0.2×FY 2020: -0.4×FY 2021: -0.3×FY 2022: -0.2×FY 2023: -0.1×FY 2024: -0.2×FY 2025: -0.1×
FY 2016 5y median -0.2× FY 2025
Net Debt / EBITDA -0.8×
FY 2016: -0.1×FY 2017: -0.1×FY 2018: -0.8×FY 2019: 4.4×FY 2020: 0.5×FY 2021: -0.4×FY 2022: 0.4×FY 2023: 0.5×FY 2024: -1.9×FY 2025: -0.8×
FY 2016 5y median -0.4× FY 2025
Interest Coverage -1.6×
FY 2016: -63.7×FY 2017: -4.4×FY 2018: -0.9×FY 2019: -0.4×FY 2020: -0.2×FY 2021: -0.5×FY 2022: -1.3×FY 2023: -2.2×FY 2024: -1.7×FY 2025: -1.6×
FY 2016 5y median -1.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.7%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -0.1%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30